Logo
Login
$BCAX
$16.78 -$0.11 (0.65%) Pre-market

Company Executives

$BCAX Management Team

Dr. Michael Powell

Independent Chairman of the Board

Age 70
Compensation $456.9K USD
Sex Male

Dr. Ryan Cohlhepp

President

Chief Operating Officer

Director

Age 48
Compensation $4.468M USD
Sex Male

Dr. Claire Mazumdar

Chief Executive Officer

Director

Age 35
Compensation $8.919M USD
Sex Female

Dr. David Raben

Chief Medical Officer

Age 61
Compensation -
Sex Male

Mr. Ivan Hyep

Chief Financial Officer

Age 40
Compensation $3.599M USD
Sex Male

Ms. Lara Meisner

Chief Legal Officer

Corporate Secretary

Age 53
Compensation -
Sex Female

Board of Directors

From the proxy statement filed Apr 27, 2026
Directors
10
serving now
Independent
8 of 10
stated in the proxy
Average tenure
3.9 years
from year joined
CEO also chairs the board
No
Michael Powell
Director Age On board Independent Committees Other public boards 2025 pay Source
Christopher Bowden
65 2024
2 years
 Independent
Compensation Committee
None stated $253,634
Carolyn Ng
42 2023
3 years
 Independent
Audit Committee
None stated Not stated
Ryan Cohlhepp
Executive officer
 49 2024
2 years
 Not independent None stated None stated Not stated
Kiran Mazumdar-Shaw
73 2018
8 years
 Independent
Nominating and Corporate Governance Committee
None stated $252,634
Jake Simson
40 2023
3 years
 Independent
Nominating and Corporate Governance Committee
Tyra Biosciences, Inc., Septerna, Inc., Janux Therapeutics, Inc. Not stated
Nils Lonberg Leaving at the meeting
70 2019
7 years
 Independent None stated None stated Not stated
Kate Haviland
50 2023
3 years
 Independent
Compensation Committee
Fulcrum Therapeutics, Inc. $253,634
Claire Mazumdar
CEO
 36 2020
6 years
 Not independent None stated Relay Therapeutics, Inc. Paid as CEO
Michael Powell
Board chair
 71 2024
2 years
 Independent
Audit Committee
None stated Not stated
Scott Robertson
46 2023
3 years
 Independent
Audit Committee · Chair
None stated $263,634

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 27, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans